According to Spectrum Pharmaceuticals 's latest financial reports the company's total assets are $0.10 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.10 B | -7.36% |
2021-12-31 | $0.11 B | -43.32% |
2020-12-31 | $0.19 B | -25.29% |
2019-12-31 | $0.26 B | -32.61% |
2018-12-31 | $0.39 B | -19.81% |
2017-12-31 | $0.48 B | 13.68% |
2016-12-31 | $0.42 B | 1.79% |
2015-12-31 | $0.42 B | -14.04% |
2014-12-31 | $0.49 B | -1.83% |
2013-12-31 | $0.49 B | -1.41% |
2012-12-31 | $0.50 B | 80.31% |
2011-12-31 | $0.28 B | 71.59% |
2010-12-31 | $0.16 B | -5.49% |
2009-12-31 | $0.17 B | 38.8% |
2008-12-31 | $0.12 B | 116.78% |
2007-12-31 | $57.54 M | 8.33% |
2006-12-31 | $53.11 M | -18.38% |
2005-12-31 | $65.07 M | 59.66% |
2004-12-31 | $40.75 M | 48.81% |
2003-12-31 | $27.38 M | 693.17% |
2002-12-31 | $3.45 M | -73.07% |
2001-12-31 | $12.82 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $195.96 B | 181,900.46% | ๐บ๐ธ USA |
![]() Novartis NVS | $110.97 B | 102,968.49% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $195.61 B | 181,573.55% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $73.79 B | 68,434.01% | ๐บ๐ธ USA |
![]() Biogen BIIB | $25.15 B | 23,263.64% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $93.48 B | 86,725.17% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $75.00 B | 69,561.39% | ๐ฌ๐ง UK |
![]() Seagen
SGEN | $3.49 B | 3,146.23% | ๐บ๐ธ USA |
![]() Curis CRIS | $84.3 M | -21.70% | ๐บ๐ธ USA |
![]() Teva Pharmaceutical Industries TEVA | $43.09 B | 39,923.22% | ๐ฎ๐ฑ Israel |